Jefferson Capital (NASDAQ: JCAP) delivers strong 2025 growth and lower leverage
Rhea-AI Filing Summary
Jefferson Capital, Inc. reported strong fourth quarter and full year 2025 results, highlighted by record performance across key metrics. Fourth quarter collections rose to $245.3 million, up 40.7% year over year, while deployments increased to $380.5 million, up 6.3%.
Estimated remaining collections reached $3.38 billion as of December 31, 2025, up 23.1% from 2024, reflecting a larger future cash flow pipeline. Fourth quarter pre-tax income grew 50% to $44.1 million, with net income of $37.7 million and EPS of $0.58. Adjusted pre-tax income was $51.1 million, and adjusted net income was $44.7 million.
For full year 2025, total revenues increased to $613.3 million from $433.3 million, and net income rose to $188.0 million from $128.9 million. The leverage ratio improved to 1.82x from 2.72x, showing stronger balance sheet capacity. The Board declared a quarterly cash dividend of $0.24 per share, payable on April 2, 2026 to shareholders of record on March 24, 2026.
Recent developments include the closing of the Bluestem portfolio purchase on December 4, 2025, which management expects to contribute meaningfully to 2026 results. In January 2026, existing stockholders sold 11.5 million shares in a secondary offering at $20.50 per share, and the company repurchased and retired 3.0 million shares, reducing J.C. Flowers’ ownership to 53% and increasing public float and liquidity.
Positive
- Strong growth in earnings and revenue: 2025 revenues increased to $613.3 million from $433.3 million and net income rose to $188.0 million from $128.9 million, reflecting substantial expansion of the business.
- Improved leverage and balance sheet flexibility: the leverage ratio declined to 1.82x from 2.72x on higher Adjusted Cash EBITDA, indicating stronger capacity to support the portfolio and funding needs.
- Record collections and larger ERC pipeline: fourth quarter 2025 collections reached $245.3 million, up 40.7%, and estimated remaining collections grew 23.1% to $3.38 billion, supporting future cash flow visibility.
- Shareholder-focused capital actions: the Board maintained a $0.24 per share quarterly dividend and the company repurchased and retired 3.0 million shares in conjunction with a secondary offering, while increasing public float and liquidity.
Negative
- None.
Insights
Results show strong growth, improving leverage and active capital management.
Jefferson Capital delivered rapid expansion in 2025, with total revenues rising from $433.3 million to $613.3 million and net income increasing from $128.9 million to $188.0 million. Strong portfolio collections and higher estimated remaining collections support a larger, more valuable asset base.
Fourth quarter collections of $245.3 million and total ERC of $3.38 billion underscore scale across the United States, Canada, the United Kingdom and Latin America. The Bluestem portfolio acquisition, closed on December 4, 2025, is expected by management to be a meaningful contributor to 2026 results, adding to growth momentum.
Leverage improved materially, with the leverage ratio declining to 1.82x from 2.72x, indicating more headroom relative to cash earnings. Capital actions were active but balanced: a secondary sale of 11.5 million shares by existing stockholders at $20.50 per share, a 3.0 million share repurchase and retirement, and a continuing quarterly dividend of $0.24 per share.

